| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.3M | -62.8% |
| R&D Expense | $114.2M | +1.1% |
| SG&A Expense | $39.2M | +8.7% |
| Operating Income | -$116.0M | -138.7% |
| Pre-tax Income | -$115.9M | -147.6% |
| Income Tax | $0 | +100.0% |
| Net Income | -$115.9M | -252.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $205.5M | +7.1% |
| Accounts Receivable | $790K | -1.0% |
| Current Assets | $310.3M | -4.2% |
| Total Assets | $339.4M | -5.4% |
| Current Liabilities | $77.9M | -22.8% |
| Total Liabilities | $339.9M | +10.0% |
| Stockholders' Equity | -$459K | -100.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.0M | -2363.4% |
| Capital Expenditures | $1.6M | -30.3% |
| Investing Cash Flow | $22.5M | +220.1% |
| Financing Cash Flow | $110.2M | +552.4% |
| Free Cash Flow | -$120.6M | -4189.5% |